Skip to main content
Figure 1 | Respiratory Research

Figure 1

From: A randomized, controlled trial to evaluate the effect of an anti-interleukin-9 monoclonal antibody in adults with uncontrolled asthma

Figure 1

Study design. aInhaled corticosteroids at stable dose: fluticasone/salmeterol (500 μg/50 μg or 250 μg/50 μg) or budesonide/formoterol (160 μg/4.5 μg). bSubjects with clinically stable asthma could reduce their inhaled corticosteroid dose to: fluticasone/salmeterol (250 μg/50 μg or 100 μg/50 μg) or budesonide/formoterol (80 μg/4.5 μg). Abbreviations: ACQ-6, Asthma Control Questionnaire-6; FEV1, Forced expiratory volume in 1 second; s.c, Subcutaneous.

Back to article page

Respiratory Research

ISSN: 1465-993X

Contact us